CAPTRUST Financial Advisors’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.27M | Buy |
85,080
+8,432
| +11% | +$324K | 0.01% | 759 |
|
|
2025
Q1 | $2.97M | Sell |
76,648
-3,874
| -5% | -$150K | 0.01% | 748 |
|
|
2024
Q4 | $2.72M | Sell |
80,522
-1,138,322
| -93% | -$38.5M | 0.01% | 757 |
|
|
2024
Q3 | $49.8M | Sell |
1,218,844
-8,239
| -0.7% | -$337K | 0.15% | 132 |
|
|
2024
Q2 | $47.2M | Sell |
1,227,083
-213,727
| -15% | -$8.23M | 0.15% | 129 |
|
|
2024
Q1 | $52.8M | Buy |
1,440,810
+226,995
| +19% | +$8.32M | 0.19% | 117 |
|
|
2023
Q4 | $45M | Sell |
1,213,815
-38,321
| -3% | -$1.42M | 0.15% | 127 |
|
|
2023
Q3 | $45.4M | Sell |
1,252,136
-7,151
| -0.6% | -$259K | 0.17% | 118 |
|
|
2023
Q2 | $44.9M | Sell |
1,259,287
-2,195
| -0.2% | -$78.2K | 0.18% | 115 |
|
|
2023
Q1 | $44.9M | Buy |
1,261,482
+73,929
| +6% | +$2.63M | 0.2% | 116 |
|
|
2022
Q4 | $41.7M | Sell |
1,187,553
-95,107
| -7% | -$3.34M | 0.21% | 106 |
|
|
2022
Q3 | $37.7M | Buy |
1,282,660
+251,352
| +24% | +$7.4M | 0.22% | 98 |
|
|
2022
Q2 | $45.2M | Buy |
1,031,308
+93,154
| +10% | +$4.09M | 0.29% | 78 |
|
|
2022
Q1 | $41.4M | Buy |
938,154
+29,228
| +3% | +$1.29M | 0.27% | 92 |
|
|
2021
Q4 | $40.5M | Sell |
908,926
-4,059
| -0.4% | -$181K | 0.28% | 91 |
|
|
2021
Q3 | $35.4M | Buy |
912,985
+140,056
| +18% | +$5.42M | 0.29% | 84 |
|
|
2021
Q2 | $31.1M | Buy |
772,929
+165,329
| +27% | +$6.65M | 0.29% | 81 |
|
|
2021
Q1 | $22.1M | Buy |
607,600
+8,387
| +1% | +$305K | 0.24% | 108 |
|
|
2020
Q4 | $22.4M | Buy |
599,213
+57,208
| +11% | +$2.14M | 0.3% | 91 |
|
|
2020
Q3 | $20.4M | Sell |
542,005
-15,202
| -3% | -$571K | 0.34% | 81 |
|
|
2020
Q2 | $23M | Sell |
557,207
-5,394
| -1% | -$223K | 0.38% | 72 |
|
|
2020
Q1 | $21.2M | Buy |
562,601
+15,464
| +3% | +$584K | 0.47% | 53 |
|
|
2019
Q4 | $25.9M | Buy |
+547,137
| New | +$25.9M | 0.41% | 66 |
|